Be at the heart of the R&D Outsourcing Community at BOS Manchester 24 with our bespoke Sponsor & Exhibitor packages. 💥 Showcase your brand, products and services. 🤝🏻 Connect face-to-face with potential outsourcing partners. 💡 Spotlight your technical & commercial developments. 🗣 Speaker presentation opportunities (Gold Sponsors only). The event will be hosted in Manchester, UK on 26th & 27th November 2024. Find out more ⬇️ https://lnkd.in/gbSqwRG5
About us
Bio2Business Ltd produces the Biotech Outsourcing Strategies Events which bring together the R&D outsourcing community to share experience, source R&D solutions and build outsourcing partnerships. Established in 2004, we have a long track record in supporting partnering in the R&D outsourcing space. We invite you to stay in the loop regarding Bio2Business Ltd & BOS Events activities by following our company!
- Website
-
http://www.bio2business.com
External link for Bio2Business Ltd
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2004
- Specialties
- Sales & Marketing, Business Development, Partnering, Outsourcing, Event Management, Exhibitions, Conferences, Biotech, Pharmaceuticals, and CROs
Locations
-
Primary
London BioScience Innovation Centre
2 Royal College Street
London, NW1 0NH, GB
Employees at Bio2Business Ltd
Updates
-
Another featured speaker announcement! We're delighted to be joined at BOS Manchester by Dr. Neil Stevenson (BenevolentAI) and Dr. David Fengas PhD FRSC (Concept Life Sciences), who will present "Process Development for the Manufacture of a Topical Pan-Trk Inhibitor Incorporating Decarboxylative Sp2-Sp3 Cross-Coupling." on 26th November at 11:00am. View the programme: https://lnkd.in/eZSpS__w
-
We are thrilled to welcome back Kreshnik Hoxha, Head of CMC and Clinical Supply Chain at Grey Wolf Therapeutics, as a featured speaker at BOS Manchester 24. During his presentation, Dr Hoxha will discuss the interface between biopharmaceutics, solubility enhancement and API polymorphism, as well as examining the interplay between these parameters in "crystallising" the drug product strategy. Be sure to listen to Dr. Hoxha on 27th November at 12:10 - 12:30pm. View the programme: https://lnkd.in/eZSpS__w
-
A warm welcome to Dr Yasunori Abe and YUJI Kanamoto, Managers at Taiho Pharmaceutical, as featured speakers at BOS Manchster 24! Their presentation focuses on Lytgobi® (futibatinib), Taiho's product marketed in the US, Japan and the EU, and discusses the control of critical quality attributes for the API and dissolution methods for the drug product. Be sure to listen to Dr. Abe and Mr. Kanamoto on 26th November at 14:00 - 14:30. View the programme: https://lnkd.in/eZSpS__w #BOSManchester24
-
We are delighted to welcome Dr Geoff Porritt from Almac Group as Gold sponsors of BOS Manchester 24. 📍 Visit their team at Stand 26. Find out more: https://lnkd.in/erHvT8Vs #BOSManchester24
-
We are delighted to welcome Dr Federico Franceschi from Olon as Silver sponsors of BOS Manchester 24. Find out more: https://lnkd.in/eF_39nKy #BOSManchester24
-
We're thrilled to introduce another featured speaker at BOS Manchester 24! Shilpi Ghosh, CDMO Chapter Lead at Roche, will be presenting "Developing Mutually Productive Outsourcing Partnerships - Pharma View" on 26th November at 14:30. View the programme: https://lnkd.in/eZSpS__w #BOSManchester24
-
We are delighted to welcome Dr Matthew Stent from Navin Molecular as Exhibition sponsors of BOS Manchester 24. 📍 Visit their team at Stand 13. Find out more: https://lnkd.in/ezs5DVeZ #BOSManchester24
-
We're pleased to welcome Dr William Goundry, Principal Scientist and AstraZeneca UK, to our programme of speakers at BOS Manchester 24. Scaling up the manufacture of highly potent ADC linker-payloads presents some key outsourcing challenges. Structures tend to be more complex with many steps of manufacturing often requiring chromatography. Additionally the final stages have to be completed in a high potency manufacturing facility. Dr. Goundry will give his perspective of how to meet these challenges with a case study on the route design and scale-up of a Topoisomerase I Inhibitor Antibody–Drug Conjugate payload. Be sure to listen to Dr. Goundry on 26th November at 13:30 - 14:00. #BOSManchester24
-
We are delighted to welcome Dr. Philip Walker, Sarah Pritchard and Shoaib Komal from Bellen Chemistry Co., Ltd. Ltd. as Exhibition sponsors of BOS Manchester 24. 📍 Visit their team at Stand 21. Find out more: https://lnkd.in/ex8XSfMK #BOSManchester24